Unique characteristics of end-of-life hospitalizations in Parkinson disease.

Whitley W Aamodt, Nabila Dahodwala, Warren B Bilker, John T Farrar, Allison W Willis
Author Information
  1. Whitley W Aamodt: Department of Neurology, University of Pennsylvania, Philadelphia, PA, United States.
  2. Nabila Dahodwala: Department of Neurology, University of Pennsylvania, Philadelphia, PA, United States.
  3. Warren B Bilker: Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, Philadelphia, PA, United States.
  4. John T Farrar: Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, Philadelphia, PA, United States.
  5. Allison W Willis: Department of Neurology, University of Pennsylvania, Philadelphia, PA, United States.

Abstract

Introduction: Persons with Parkinson disease (PD) are hospitalized at higher rates, have longer lengths of stay, and are more likely to die in the hospital than age-matched peers. Although prior studies have compared inpatient outcomes between persons with and without PD, little is known about inpatient outcomes across the PD trajectory, or whether hospitalizations occurring in the last 6���months of life differ from earlier hospitalizations.
Methods: This cross-sectional study compared Medicare Part A and B beneficiaries aged 65 and older with a qualifying PD diagnosis who were hospitalized in 2017: decedents who died between 7/1/2017 and 12/31/2017 from all causes and were hospitalized at least once in their last 6���months of life, and non-decedents who were hospitalized between 1/1/2017 and 6/30/2017 and lived 6 or more months after discharge. End-of-life (EoL) hospitalizations were defined as those occurring in the last 6���months of life. Descriptive analyses compared patient-level variables (e.g., demographics, comorbidities, treatment intensity) and encounter-level variables (e.g., length of stay, total charges) between groups. Multivariable logistic regression models also compared rates of intensive care unit (ICU) admission and 30-day readmission between hospitalized decedents and hospitalized non-decedents, adjusting for age, sex, race/ethnicity, rural residence, and Charlson Comorbidity Index Score.
Results: Of 26,492 Medicare decedents with PD, 16,187 (61.1%) were hospitalized in their last 6���months of life. Of 347,512 non-decedents with PD, 62,851 (18.1%) were hospitalized in a 6-month period. Hospitalized decedents were slightly older than hospitalized non-decedents (82.3 [SD 7.40] vs. 79.5 [SD 7.54] years) and had significantly more comorbidities. Compared to non-EoL hospitalizations, EoL hospitalizations were slightly longer (5 [IQR 3-9] vs. 4 [IQR 3-7] days) and more expensive based on total charges per admission ($36,323 [IQR 20,091-69,048] vs. $32,309 [IQR 18,789-57,756]). In covariate-adjusted regression models using hospitalized non-decedents as the reference group, hospitalized decedents were more likely to experience an ICU admission (AOR 2.36; CI 2.28-2.45) and 30-day readmission (AOR 2.43; CI 2.34-2.54).
Discussion: Hospitalizations occurring in the last 6���months of life among persons with PD in the United States are longer, more costly, and more resource intensive than earlier hospitalizations and may stem from medical comorbidities. Once hospitalized, ICU admission and 30-day readmission may aid in prognostication and serve as markers of transition to the EoL period.

Keywords

References

  1. BMC Geriatr. 2020 Nov 11;20(1):467 [PMID: 33176721]
  2. J Am Geriatr Soc. 1999 Aug;47(8):967-72 [PMID: 10443858]
  3. BMC Neurol. 2012 Mar 08;12:13 [PMID: 22400982]
  4. J Pain Symptom Manage. 2014 Jan;47(1):77-89 [PMID: 23796586]
  5. Sci Rep. 2023 Jun 1;13(1):8911 [PMID: 37264048]
  6. Nat Hum Behav. 2022 Dec;6(12):1649-1659 [PMID: 36253520]
  7. Parkinsonism Relat Disord. 2015 May;21(5):449-54 [PMID: 25737205]
  8. Natl Vital Stat Rep. 2019 Jun;68(9):1-77 [PMID: 32501199]
  9. Health Aff (Millwood). 2017 Jul 1;36(7):1211-1217 [PMID: 28679807]
  10. J Chronic Dis. 1987;40(5):373-83 [PMID: 3558716]
  11. Mov Disord. 2005 Sep;20(9):1104-8 [PMID: 15884038]
  12. South Med J. 2014 Mar;107(3):178-85 [PMID: 24937337]
  13. Parkinsonism Relat Disord. 2014 May;20(5):488-92; discussion 488 [PMID: 24582073]
  14. NPJ Parkinsons Dis. 2018 Jul 10;4:21 [PMID: 30003140]
  15. JAMA. 2013 Feb 6;309(5):470-7 [PMID: 23385273]
  16. Parkinsonism Relat Disord. 2011 Mar;17(3):139-45 [PMID: 21159538]
  17. Health Care Financ Rev. 2006 Summer;27(4):95-110 [PMID: 17290660]
  18. Palliat Med. 2017 Dec;31(10):932-945 [PMID: 28429629]
  19. Parkinsonism Relat Disord. 2013 Nov;19(11):949-54 [PMID: 23835430]
  20. JAMA. 2018 Jul 17;320(3):264-271 [PMID: 29946682]
  21. Ann Indian Acad Neurol. 2019 Jan-Mar;22(1):79-83 [PMID: 30692764]
  22. Am J Hosp Palliat Care. 2019 Aug;36(8):705-710 [PMID: 30884954]
  23. JAMA. 2018 Jul 17;320(3):239-241 [PMID: 30027232]
  24. J Geriatr Psychiatry Neurol. 2023 Aug 8;:8919887231195219 [PMID: 37551798]
  25. Mov Disord. 2011 Feb 1;26(2):197-208 [PMID: 21284037]
  26. Parkinsonism Relat Disord. 2020 Feb;71:66-72 [PMID: 32156461]
  27. Med Care. 1998 Mar;36(3):411-21 [PMID: 9520964]
  28. Neurosurgery. 2020 Apr 1;86(4):524-529 [PMID: 31432068]
  29. Med Care. 2005 Nov;43(11):1130-9 [PMID: 16224307]
  30. J Parkinsons Dis. 2020;10(4):1577-1586 [PMID: 32597816]
  31. Parkinsonism Relat Disord. 2012 Sep;18(8):930-5 [PMID: 22621819]
  32. J Palliat Med. 2005;8 Suppl 1:S12-21 [PMID: 16499460]
  33. Neurol Clin Pract. 2022 Dec;12(6):388-396 [PMID: 36540145]
  34. J Clin Neurosci. 2017 Mar;37:57-58 [PMID: 27810417]
  35. Crit Care Med. 2016 Apr;44(4):655-62 [PMID: 26571190]
  36. NAM Perspect. 2021 Apr 07;2021: [PMID: 34532691]
  37. PLoS One. 2015 Apr 17;10(4):e0124356 [PMID: 25884484]
  38. JAMA Netw Open. 2023 Aug 1;6(8):e2327485 [PMID: 37566420]
  39. PLoS One. 2017 Jul 6;12(7):e0180425 [PMID: 28683150]
  40. J Arthroplasty. 2019 Jul;34(7S):S228-S231 [PMID: 30982760]
  41. Neurol Clin Pract. 2023 Aug;13(4):e200171 [PMID: 37251369]
  42. Int J Environ Res Public Health. 2022 Feb 03;19(3): [PMID: 35162772]
  43. JAMA. 2012 Jan 11;307(2):165-72 [PMID: 22235087]
  44. Parkinsons Dis. 2021 Nov 05;2021:2948323 [PMID: 34777783]
  45. Aging Clin Exp Res. 2021 Apr;33(4):991-996 [PMID: 32488473]

Grants

  1. K24 AG075234/NIA NIH HHS
  2. T32 NS061779/NINDS NIH HHS

Word Cloud

Created with Highcharts 10.0.0hospitalizedPDhospitalizationslast6���monthslifedecedentsnon-decedentscomparedadmission[IQR2ParkinsondiseaselongerstayoccurringEoLcomorbiditiesintensiveICU30-dayreadmissionvsrateslikelyinpatientoutcomespersonsearlierMedicareoldervariableseglengthtotalchargesregressionmodelscareunit1%18periodslightly[SD75AORCImayIntroduction:Personshigherlengthsdiehospitalage-matchedpeersAlthoughpriorstudieswithoutlittleknownacrosstrajectorywhetherdifferMethods:cross-sectionalstudyPartBbeneficiariesaged65qualifyingdiagnosis2017:died7/1/201712/31/2017causesleast1/1/20176/30/2017lived6monthsdischargeEnd-of-lifedefinedDescriptiveanalysespatient-leveldemographicstreatmentintensityencounter-levelgroupsMultivariablelogisticalsoadjustingagesexrace/ethnicityruralresidenceCharlsonComorbidityIndexScoreResults:264921618761347512628516-monthHospitalized82340]7954]yearssignificantlyComparednon-EoL3-9]43-7]daysexpensivebasedper$3632320091-69048]$32309789-57756]covariate-adjustedusingreferencegroupexperience3628-2454334-254Discussion:HospitalizationsamongUnitedStatescostlyresourcestemmedicalaidprognosticationservemarkerstransitionUniquecharacteristicsend-of-lifecosthospitalizationmortality

Similar Articles

Cited By